Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

American Journal of Human Genetics

Volumn 64, Issue 5, 1999, Pages 1371-1377

  Rebbeck, Timothy R ^b   Kantoff, Philip W ^c   Krithivas, Krishna ^c   Neuhausen, Susan ^a   Blackwood, M Anne ^c   Godwin, Andrew K ^c   Daly, Mary B ^c   Narod, Steven A ^c   Garber, Judy E ^c   Lynch, Henry T ^c   Weber, Barbara L ^c   Brown, Myles ^c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; DNA;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

EID: 0001516492     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302366     Document Type: Article

References (25)

1. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD (1995) Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52:459-467
2. Birrell SN, Hall RE, Tilley WD (1998) Role of the androgen receptor in human breast cancer. J Mamm Gland Biol Neoplasia 3:95-103
3. Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186
4. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 56:265-271
5. Eeles RA, Edwards SM, Minter R, Hamoudi R, Collins N, Shearer R, Easton DF, et al (1998) Androgen receptor polymorphisms: their association with prostate cancer risk, relapse, and overall survival. Am J Hum Genet 63:A21
6. Elhaji Y, Trifiro M, Pinsky L (1997) The polymorphic CAG repeat of the androgen receptor and female breast cancer. Am J Hum Genet 61:A64
7. Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, et al (1995) Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-433
8. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, et al (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323
9. Goldenberg IS, Waters N, Ravdin RS, Ansfield FJ, Segaloff A (1973) Androgenic therapy for advanced breast cancer in women: a report of the Cooperative Breast Cancer Group. JAMA 223:1267-1268
10. Gudas JM, Nguyen H, Li T, Cowan KH (1995) Hormone-dependent regulation of BRCA1 in human breast cancer cells. Cancer Res 55:4561-4565
11. Hackenberg R, Schulz KD (1996) Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids. J Steroid Biochem Mol Biol 56:113-117
12. Hakimi JM, Schoenberg MP, Rondinelli RH, Piatadosi S, Barrack ER (1997) Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin Cancer Res 3:1599-1608
13. Hardy DO, Scher HI, Bogenreider T, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF (1996) Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab 81:4400-4405
14. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89:166-170
15. Kazemi-Esfarjani P, Trifiro MA, Pinsky L (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4:523-527
16. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
17. Lin DY, Wei LJ (1989) Robust inferences for the Cox proportional hazards model. J Am Stat Assoc 84:1074-1078
18. Marks JR, Huper G, Vaughn JP, Davis PL, Norris J, McDonnell DP, Wiseman RW, et al (1997) BRCA1 expression is not directly responsive to estrogen. Oncogene 14:115-121
19. Narod SA, Goldgar D, Cannon-Albright L, Weber BL, Moslehi R, Ives E, Lenoir G, et al (1995) Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64:394-398
20. Rebbeck TR (1999) Cancer risk modifying factors in BRCA1 mutation carriers. In: Utsunomiya J, Mulvihill J, Weber W, Yuasa Y (eds) Proceedings of the UICC Symposium. Familial cancer and prevention: molecular epidemiology. John Wiley and Sons, New York
21. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. New Eng J Med 336:1401-1408
22. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Young EL (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82:3777-3782
23. Szelei J, Jimenez J, Soto AM, Luizzi MF, Sonnenschein C (1997) Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138:1406-1412
24. Zeleniuch-Jaquotte A, Bruning PF, Bonfrer JM, Koenig KL, Shore RE, Kim MY, Pasternack BS, et al (1997) Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 145:1030-1038
25. Zhu X, Daffada AA, Chan CM, Dowsett M (1997) Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer. Int J Cancer 72:574-580